CUA Urology WebEx Series

 

Upcoming Online Events

January 22, 2020 
17:00 PST | 20:00 EST | 21:00 AST

New treatment options for adults and children with overactive bladder
Speaker: Dean Elterman (University Health Network, University of Toronto, Krembil Research Institute)

> review the prevalence of OAB
> improve management skills with 1st and 2nd line treatment options
> CUA OAB Guidelines discussion 


 tal.erdman@cua.org



February 4, 2020 
17:00 PST | 20:00 EST | 21:00 AST

Advanced Urothelial Carcinoma: Emerging Therapies and Biomarker-Driven Patient Selection
Speaker: Scott North (University of Alberta, Cross Cancer Institute)

> Canadian GU Research Consortium (GURC) algorithm for advanced urothelial carcinoma
> optimal timing of biomarker testing
> FGFR inhibitors


tal.erdman@cua.org



February 13-15, 2020 
CUA LIVE FROM GU ASCO 2020 San Francisco



February 13: Prostate Cancer
17:00 PST | 20:00 EST | 21:00 AST
Fred Saad & Sebastien Hotte & Guest Speaker -> Nicholas James 

February 14: Bladder Cancer
17:00 PST | 20:00 EST | 21:00 AST
Peter Black & Scott North

February 15: Kidney Cancer
17:00 PST | 20:00 EST | 21:00 AST
Anil Kapoor & Christian Kollmannsberger

 tal.erdman@cua.org


 

ARCHIVED VIDEO RECORDINGS



Transvaginal mesh in the management of SUI: Addressing your concerns

 

Dr. Kevin Carlson & Dr. Blayne Welk

 

 

New Treatment Options for Adults and Children with Overactive Bladder

Dr. Sender Herschorn

 

<CLAIM SECTION 3 CREDITS BY CLICKING HERE>

 

Monitoring Prostate Cancer to Guide Treatment Decision-Making 

Dr. Ricardo Rendon
Dr. Fred Saad

 

 <CLAIM SECTION 3 CREDITS BY CLICKING HERE>

 

What's new in RCC and implications for patients in Canada

 

Debate: In the second line setting, how do you make clinical decisions in tha absence of evidence?

 

Dr. Aly-Khan Lalani | Dr. Anil Kapoor vs. Dr. Sebastien Hotte

 
 <CLAIM SECTION 3 CREDITS BY CLICKING HERE>

 

TSC related Angiomyolipoma - Management Strategies and Case Studies

Dr. Anil Kapoor

 

 <CLAIM SECTION 3 CREDITS BY CLICKING HERE>

 

New Immuno-oncology Combinations for Untreated Metastatic Kidney Cancer: An Emerging New Standard of Care?

 

Dr. Scott North & Dr. Anil Kapoor

 

 <CLAIM SECTION 3 CREDITS BY CLICKING HERE>

 

New Immuno-oncology Combinations for Untreated Metastatic Kidney Cancer: An Emerging New Standard of Care?

Dr. Scott North & Dr. Anil Kapoor


Testosterone Suppression in the Treatment of Recurrent or Metastatic Prostate Cancer - A Canadian Consensus Statement 

Dr. Laurie Klotz

 

New Developments in the management of metastatic prostate cancer: A look back at 2017

What is the optimal role for bone targeted therapy in the changing landscape of prostate cancer?

 

Fred Saad
Dr. Anil Kapoor

Live From the CUA: New Developments in the Management of Advanced Prostate Cancer:
Impact on Cancer Care in Canada

Introduction
Dr.Kim Chi
Dr.Alan So and Dr. Fred Saad
Q & A

Present and Future of Prostate Cancer Conventional and Molecular Imaging

 

CUA Webseries: 2015-2016

 

 

The CUA WebEx series is supported by an educational grant from: